Rechallenge temozolomide in glioma: A case series from India.
Sign Up to like & getrecommendations! Published in 2017 at "Indian journal of cancer"
DOI: 10.4103/ijc.ijc_173_17
Abstract: INTRODUCTION Temozolomide (TMZ) is an integral part of upfront treatment of high-grade gliomas. It is administered postsurgery as concurrent therapy with radiation and subsequently as adjuvant chemotherapy for 6-12 cycles. It is unknown whether rechallenge… read more here.
Keywords: glioma case; glioma; analysis; temozolomide glioma ... See more keywords